Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter Suzdak, PhD, the Company’s Chief Executive Officer, will be presenting at the Biotech Showcase 2014 Conference being held in San Francisco, CA. The presentation will be on Tuesday, January 14, 2014 at 9:30am PST. A webcast of the presentation will be available on www.rexahn.com.
Help employers find you! Check out all the jobs and post your resume.
